These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 11365126)
1. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
2. Fortovase approved: new saquinavir formulation. James JS AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907 [TBL] [Abstract][Full Text] [Related]
3. FDA notifications. Potential serious effect of combination saquinavir-ritonavir. AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774 [No Abstract] [Full Text] [Related]
5. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers. James JS AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073 [TBL] [Abstract][Full Text] [Related]
6. Roche brings new formulation of saquinavir to FDA. Food and Drug Administration. Cadman J GMHC Treat Issues; 1997; 11(4/5):8. PubMed ID: 11364377 [TBL] [Abstract][Full Text] [Related]
7. Saquinavir (Fortovase or Invirase). Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182 [No Abstract] [Full Text] [Related]
8. Why the old saquinavir (Invirase) may be bad for your health. Vazquez E Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485 [TBL] [Abstract][Full Text] [Related]
9. New saquinavir formula more potent than original. Bartnof HS BETA; 1997 Sep; ():45. PubMed ID: 11364701 [TBL] [Abstract][Full Text] [Related]
10. Roche submits NDA for Invirase. J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796 [TBL] [Abstract][Full Text] [Related]
11. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase. TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608 [No Abstract] [Full Text] [Related]
12. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [TBL] [Abstract][Full Text] [Related]
13. Saquinavir plus ritonavir reduce viral load by 99.9 percent. Vazquez E Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up. Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062 [TBL] [Abstract][Full Text] [Related]
15. Improved but not new. Vazquez E Posit Aware; 1997; 8(6):19. PubMed ID: 11364855 [TBL] [Abstract][Full Text] [Related]
16. New study of Fortovase (Saquinavir) in women. WORLD; 1998 Nov; (No 91):4. PubMed ID: 11365973 [TBL] [Abstract][Full Text] [Related]
17. NDA submitted for new formulation of saquinavir. AIDS Patient Care STDS; 1997 Aug; 11(4):288-9. PubMed ID: 11361847 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection. Wheat LJ; Farthing C; Cohen C; Pierone G; Lalezari J; Pilson RS; Siemon-Hryczyk P; Antivir Ther; 2002 Sep; 7(3):199-209. PubMed ID: 12487388 [TBL] [Abstract][Full Text] [Related]